N/A
N=40
Diagnostic Ultrasound for Measuring Fat of the Body
Subcutaneous Fat
Bottom Line
View on ClinicalTrials.gov: NCT03871556 ↗Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Sep 2023
Primary outcome: Primary: Difference in Thickness of Subcutaneous Fat at Different Anatomic Sites on the Body — .56; .60; .83; 1.65 average fat measurement (cm)
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- LOGIQ P6 Diagnostic Ultrasound (Diagnostic_test)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Northwestern University
- Primary completion
- Oct 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Difference in Thickness of Subcutaneous Fat at Different Anatomic Sites on the Body |
.56; .60; .83; 1.65; .82; 1.72 | — |
| PRIMARY Gender Differences on Patient Perceptions of Body Image With Measured Fat Distribution |
8.48; 5.14; 7.41; 4.02; 7.90; 5.18 | — |
Summary
The purpose of this study is to provide information about human subcutaneous fat thickness at different anatomic sites on the body by measuring these thicknesses with a diagnostic ultrasound and also by correlating patient perceptions of body image with measured fat distribution.
Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.
Eligibility Criteria
Inclusion Criteria
- Males or females 18-85 years old.
- Subjects are in good health as judged by the investigator.
- Subjects with Body Mass Index (BMI) between 18-29.99.
- Subjects who are willing and have the ability to understand and provide informed consent for participation in the study and are able to communicate with the investigator
Exclusion Criteria
- Evidence of another skin condition affecting the treatment area that would interfere with clinical assessments
- Pregnant or breast feeding
- Uncooperative patients or patients with neurological disorders who are incapable of following directions
- Subjects who are unable to understand the protocol or give informed consent (including non-English speaking patients)
Data sourced from ClinicalTrials.gov (NCT03871556). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.